First Time Loading...

Mediwound Ltd
NASDAQ:MDWD

Watchlist Manager
Mediwound Ltd Logo
Mediwound Ltd
NASDAQ:MDWD
Watchlist
Price: 17.643 USD -0.38% Market Closed
Updated: May 10, 2024

Intrinsic Value

MediWound Ltd. is a biopharmaceutical company engaging in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard... [ Read More ]

The intrinsic value of one MDWD stock under the Base Case scenario is 10.249 USD. Compared to the current market price of 17.643 USD, Mediwound Ltd is Overvalued by 42%.

Key Points:
MDWD Intrinsic Value
Base Case
10.249 USD
Overvaluation 42%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Mediwound Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MDWD stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Mediwound Ltd

Provide an overview of the primary business activities
of Mediwound Ltd.

What unique competitive advantages
does Mediwound Ltd hold over its rivals?

What risks and challenges
does Mediwound Ltd face in the near future?

Summarize the latest earnings call
of Mediwound Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mediwound Ltd.

Provide P/S
for Mediwound Ltd.

Provide P/E
for Mediwound Ltd.

Provide P/OCF
for Mediwound Ltd.

Provide P/FCFE
for Mediwound Ltd.

Provide P/B
for Mediwound Ltd.

Provide EV/S
for Mediwound Ltd.

Provide EV/GP
for Mediwound Ltd.

Provide EV/EBITDA
for Mediwound Ltd.

Provide EV/EBIT
for Mediwound Ltd.

Provide EV/OCF
for Mediwound Ltd.

Provide EV/FCFF
for Mediwound Ltd.

Provide EV/IC
for Mediwound Ltd.

Show me price targets
for Mediwound Ltd made by professional analysts.

What are the Revenue projections
for Mediwound Ltd?

How accurate were the past Revenue estimates
for Mediwound Ltd?

What are the Net Income projections
for Mediwound Ltd?

How accurate were the past Net Income estimates
for Mediwound Ltd?

What are the EPS projections
for Mediwound Ltd?

How accurate were the past EPS estimates
for Mediwound Ltd?

What are the EBIT projections
for Mediwound Ltd?

How accurate were the past EBIT estimates
for Mediwound Ltd?

Compare the revenue forecasts
for Mediwound Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Mediwound Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mediwound Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mediwound Ltd compared to its peers.

Compare the P/E ratios
of Mediwound Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Mediwound Ltd with its peers.

Analyze the financial leverage
of Mediwound Ltd compared to its main competitors.

Show all profitability ratios
for Mediwound Ltd.

Provide ROE
for Mediwound Ltd.

Provide ROA
for Mediwound Ltd.

Provide ROIC
for Mediwound Ltd.

Provide ROCE
for Mediwound Ltd.

Provide Gross Margin
for Mediwound Ltd.

Provide Operating Margin
for Mediwound Ltd.

Provide Net Margin
for Mediwound Ltd.

Provide FCF Margin
for Mediwound Ltd.

Show all solvency ratios
for Mediwound Ltd.

Provide D/E Ratio
for Mediwound Ltd.

Provide D/A Ratio
for Mediwound Ltd.

Provide Interest Coverage Ratio
for Mediwound Ltd.

Provide Altman Z-Score Ratio
for Mediwound Ltd.

Provide Quick Ratio
for Mediwound Ltd.

Provide Current Ratio
for Mediwound Ltd.

Provide Cash Ratio
for Mediwound Ltd.

What is the historical Revenue growth
over the last 5 years for Mediwound Ltd?

What is the historical Net Income growth
over the last 5 years for Mediwound Ltd?

What is the current Free Cash Flow
of Mediwound Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mediwound Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mediwound Ltd

Current Assets 49.7m
Cash & Short-Term Investments 71.6m
Receivables 5.1m
Other Current Assets -27m
Non-Current Assets 16.8m
PP&E 15.9m
Intangibles 165k
Other Non-Current Assets 673k
Current Liabilities 10.8m
Accounts Payable 5.5m
Other Current Liabilities 5.3m
Non-Current Liabilities 24m
Long-Term Debt 6.4m
Other Non-Current Liabilities 17.7m
Efficiency

Earnings Waterfall
Mediwound Ltd

Revenue
18.7m USD
Cost of Revenue
-15.1m USD
Gross Profit
3.6m USD
Operating Expenses
-19.1m USD
Operating Income
-15.5m USD
Other Expenses
8.8m USD
Net Income
-6.7m USD

Free Cash Flow Analysis
Mediwound Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

MDWD Profitability Score
Profitability Due Diligence

Mediwound Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Exceptional ROIC
Exceptional Revenue Growth Forecast
59/100
Profitability
Score

Mediwound Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

MDWD Solvency Score
Solvency Due Diligence

Mediwound Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
61/100
Solvency
Score

Mediwound Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MDWD Price Targets Summary
Mediwound Ltd

Wall Street analysts forecast MDWD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDWD is 29.07 USD with a low forecast of 25.25 USD and a high forecast of 37.8 USD.

Lowest
Price Target
25.25 USD
43% Upside
Average
Price Target
29.07 USD
65% Upside
Highest
Price Target
37.8 USD
114% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

MDWD Price
Mediwound Ltd

1M 1M
+15%
6M 6M
+129%
1Y 1Y
+70%
3Y 3Y
-39%
5Y 5Y
-44%
10Y 10Y
-77%
Annual Price Range
17.643
52w Low
7.18
52w High
19.27
Price Metrics
Average Annual Return -16.83%
Standard Deviation of Annual Returns 25.97%
Max Drawdown -83%
Shares Statistics
Market Capitalization 162.7m USD
Shares Outstanding 9 491 720
Percentage of Shares Shorted 2.16%

MDWD Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Mediwound Ltd Logo
Mediwound Ltd

Country

Israel

Industry

Pharmaceuticals

Market Cap

162.7m USD

Dividend Yield

0%

Description

MediWound Ltd. is a biopharmaceutical company engaging in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. The firm focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The firm's product, NexoBrid, is indicated for the removal of dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns, also referred to as severe burns. The firm sells NexoBrid in Europe and Israel. NexoBrid is a topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues. Its product, EscharEx, is a topical biological drug, which is being developed for debridement of chronic and other hard-to-heal wounds. NexoBrid and EscharEx are based on its proteolytic enzyme technology. The firm is also developing an injectable product based on its proteolytic enzyme technology for connective tissue pathologies and indications.

Contact

YAVNE
42 Hayarkon Street
+972779714100.0
http://www.mediwound.com

IPO

2014-03-20

Employees

77

Officers

Chief Financial Officer
Ms. Hani Luxenburg
Chief Executive Officer
Mr. Ofer Gonen B.Sc.
Co-Founder
Dr. Lior Rosenberg M.D.
COO & Chief Commercial Officer
Dr. Shmulik Hess Ph.D.
Executive VP, General Counsel & Corporate Secretary
Mr. Yaron Meyer Adv.
Executive Vice President of Strategy & Corporate Development
Mr. Barry J. Wolfenson
Show More
Chief Research & Development Officer
Dr. Ety Klinger MBA, Ph.D.
Chief Medical Officer
Dr. Robert J. Snyder CWS, D.P.M., F.A.C.F.A.S., FFPM, M.B.A., M.Sc.
Show Less

See Also

Discover More
What is the Intrinsic Value of one MDWD stock?

The intrinsic value of one MDWD stock under the Base Case scenario is 10.249 USD.

Is MDWD stock undervalued or overvalued?

Compared to the current market price of 17.643 USD, Mediwound Ltd is Overvalued by 42%.